These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 25368291)
1. Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder. Klopfer K; Delahunt B; Adamson M; Samaratunga H Anticancer Res; 2014 Nov; 34(11):6779-84. PubMed ID: 25368291 [TBL] [Abstract][Full Text] [Related]
2. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. Li W; Liang Y; Deavers MT; Kamat AM; Matin SF; Dinney CP; Czerniak B; Guo CC Am J Clin Pathol; 2014 Dec; 142(6):864-71. PubMed ID: 25389341 [TBL] [Abstract][Full Text] [Related]
3. Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Samaratunga H; Delahunt B Pathology; 2012 Aug; 44(5):407-18. PubMed ID: 22777074 [TBL] [Abstract][Full Text] [Related]
5. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579 [TBL] [Abstract][Full Text] [Related]
6. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175 [TBL] [Abstract][Full Text] [Related]
7. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859 [TBL] [Abstract][Full Text] [Related]
8. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Cox R; Epstein JI Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490 [TBL] [Abstract][Full Text] [Related]
9. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337 [TBL] [Abstract][Full Text] [Related]
10. Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation. Samaratunga H; Delahunt B; Egevad L; Adamson M; Hussey D; Malone G; Hoyle K; Nathan T; Kerle D; Ferguson P; Nacey JN Histopathology; 2016 Mar; 68(4):533-40. PubMed ID: 26211928 [TBL] [Abstract][Full Text] [Related]
11. Utility of uroplakin II expression as a marker of urothelial carcinoma. Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878 [TBL] [Abstract][Full Text] [Related]
13. A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder. Hoang LL; Tacha DE; Qi W; Yu C; Bremer RE; Chu J; Haas TS; Cheng L Arch Pathol Lab Med; 2014 Jul; 138(7):943-9. PubMed ID: 24978921 [TBL] [Abstract][Full Text] [Related]
14. Significance of uroplakin III expression in recurrence of solitary muscle non-invasive bladder cancer. Tadin T; Krpina K; Štifter S; Babarović E; Jonjić N Pathol Res Pract; 2014 May; 210(5):279-84. PubMed ID: 24553301 [TBL] [Abstract][Full Text] [Related]
15. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma. Behzatoğlu K; Yörükoğlu K; Demir H; Bal N Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats. Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780 [TBL] [Abstract][Full Text] [Related]
17. Invasive micropapillary urothelial carcinoma of the bladder. Lopez-Beltran A; Montironi R; Blanca A; Cheng L Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120 [TBL] [Abstract][Full Text] [Related]
18. Uroplakin II outperforms uroplakin III in diagnostically challenging settings. Smith SC; Mohanty SK; Kunju LP; Chang E; Chung F; Carvalho JC; Paner GP; Hansel DE; Luthringer DJ; de Peralta-Ventrurina MN; Amin MB Histopathology; 2014 Jul; 65(1):132-8. PubMed ID: 24382161 [TBL] [Abstract][Full Text] [Related]
19. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762 [TBL] [Abstract][Full Text] [Related]
20. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Wasco MJ; Daignault S; Bradley D; Shah RB Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]